Content about Bristol-Myers Squibb

March 2, 2010

Bristol-Myers Squibb CEO James Cornelius will retire. He will replaced by Lamberto Andreotti, Bristol announced...

March 2, 2010

The Food and Drug Administration has declined to approve a biotech drug for organ transplant...

March 1, 2010

The Food and Drug Administration has recommended approval for a biotech drug for treating kidney...

February 11, 2010

Some investors quoted in published reports foresee huge gains for such retail pharmacy chains as...

WHAT IT MEANS AND WHY ITS IMPORTANT Some investors quoted in published reports foresee huge gains for such retail pharmacy chains as CVS and Walgreens, as blockbuster drugs like Pfizer’s Lipitor (atorvastatin) and Sanofi-Aventis’ and Bristol-Myers Squibb’s Plavix (clopidogrel bisulfate) come off patent and face generic competition, but they would do well to remember an important factor: the patent cliff.

February 7, 2010

Patent expiries on blockbuster branded drugs could mean huge profits for some retail pharmacy chains,...

January 31, 2010

A rare but serious liver disorder has been reported in some patients taking a drug...

January 5, 2010

A research firm for pharmaceutical and healthcare issues projected sales of more than $1 billion...

December 10, 2009

PricewaterhouseCoopers’ report that the personalized medicine market will grow 11% per year is just another...

NEW YORK PricewaterhouseCoopers’ report that the personalized medicine market will grow 11% per year is just another indication that the field could become the next generation of community pharmacy.

November 15, 2009

Don’t be surprised to see an “Under New Management” sign hanging from the door of...

NEW YORK Don’t be surprised to see an “Under New Management” sign hanging from the door of Mead Johnson’s doors sometime soon — the split-off makes it easier now for Mead Johnson to be acquired, and it just may be a very lucrative target.